SAREPTA THERAPEUTICS, INC. Public Float
SAREPTA THERAPEUTICS, INC. (SRPT) had Public Float of $1.67 billion as of 2025-06-30, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-02
- 2025-06-30: Entity Public Float $1.67B.
- 2024-06-30: Entity Public Float $15.05T.
- 2023-06-30: Entity Public Float $10.68T.
- 2022-06-30: Entity Public Float $6.56T.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $1.67B 10-K · filed 2026-03-02 |
| 2024-06-30 | $15.05T 10-K · filed 2025-02-28 |
| 2023-06-30 | $10.68T 10-K · filed 2024-02-28 |
| 2022-06-30 | $6.56T 10-K · filed 2023-02-28 |
| 2021-06-30 | $6.21B 10-K · filed 2022-03-01 |
| 2020-06-30 | $12.58B 10-K · filed 2021-03-01 |
| 2019-06-28 | $11.29B 10-K · filed 2020-02-26 |
| 2018-06-29 | $8.77B 10-K · filed 2019-02-28 |
| 2017-06-30 | $1.87B 10-K · filed 2018-03-01 |
| 2016-06-30 | $912.88M 10-K · filed 2017-02-28 |
| 2015-06-30 | $1.26B 10-K · filed 2016-02-25 |
| 2014-06-30 | $1.22B 10-K · filed 2015-02-26 |
| 2013-06-30 | $1.23B 10-K · filed 2014-03-03 |
| 2012-06-30 | $84.28M 10-K · filed 2013-03-15 |
| 2011-06-30 | $192.64M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |